Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Strata Skin Sciences markets FDA-cleared excimer laser and lamp systems for targeted UVB light therapy, primarily for dermatologic conditions such as psoriasis, vitiligo, atopic dermatitis, leukoderma, and acne. The XTRAC platform is widely used in the U.S. and internationally with over 2,000 devices installed globally. Clinical studies support its efficacy with high clearance rates for psoriasis and other inflammatory skin diseases; the company continues to expand insurance coverage and indications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Strata Skin Sciences.